Featured Research

from universities, journals, and other organizations

Stem cell treatment is effective for certain cases of acute leukemia

Date:
December 13, 2010
Source:
Health Behavior News Service, part of the Center for Advancing Health
Summary:
Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.

Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.

Acute leukemias -- classified as either acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) -- are fast-moving cancers that attack the bone marrow and blood. Along with chemotherapy, the treatment for the disease can include transplanting stem cells that can replenish the body's supply of healthy blood cells.

The new stem cells can come from donors, such as a patient's sibling, whose blood cells carry matching molecular markers to the patient. The transplant can also be made using some of the patient's own stem cells.

Stem cell therapy is an alternative treatment that could "reduce the risk of relapse or even cure the disease when chemotherapy alone fails to eradicate the disease," said review co-author Yen-Fu Chen, Ph.D., of the University of Birmingham, in England, and project leader from the West Midlands Health Technology Assessment Collaboration.

However, the transplants, used in place of or along with chemotherapy, have varying rates of success "depending on the type of leukemia and certain risk factors that individual patients possess," said Khalid Ashfaq, M.D., the first author of the review.

The review is published in the latest issue of Health Technology Assessment, the international journal series of the Health Technology Assessment program, part of the National Institute for Health Research in the United Kingdom.

The researchers found that treatment using a sibling's stem cells might be more effective than chemotherapy in children and adults with AML who have entered their first remission from the disease. "This is the case except in some adults, who have a good risk profile," said Chen. Adults with ALL in their first remission also live longer and suffer fewer relapses with the stem cell transplants, they found.

When using the patient's own stem cells, however, stem cell treatment generally fared no better -- and sometimes fared worse -- than chemotherapy, according to Chen and colleagues.

The 15 analyses reviewed by the researchers, which comprised more than 2,000 patients, revealed several significant gaps in the evidence about stem cell treatments. For patients who had suffered more than one relapse of their leukemia, for instance, there were not enough data to say whether a stem cell transplant would be a better treatment than chemotherapy.

Decisions surrounding the specific techniques used in the transplantation, "such as to what extent the patient's blood generating system needs to be destroyed before the transplant, using different conditioning regimes," Chen said, might also play a role in how well a stem cell treatment works. Yet, "there is not enough good-quality evidence to really be able to make a recommendation at the moment," he added.

"It is encouraging that several clinical trials addressing this issue are underway, and we will have much more evidence to answer the question in a few years' time," Chen said.

The study also looked into whether stem cell transplantation for treating acute leukemia "is of good value for the money" under various health services plans internationally, but there was not enough information on cost "for a comprehensive assessment," Ashfaq said.


Story Source:

The above story is based on materials provided by Health Behavior News Service, part of the Center for Advancing Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ashfaq K, et al. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review. Health Technol Assess, 2010; 14(54)

Cite This Page:

Health Behavior News Service, part of the Center for Advancing Health. "Stem cell treatment is effective for certain cases of acute leukemia." ScienceDaily. ScienceDaily, 13 December 2010. <www.sciencedaily.com/releases/2010/12/101210095715.htm>.
Health Behavior News Service, part of the Center for Advancing Health. (2010, December 13). Stem cell treatment is effective for certain cases of acute leukemia. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/12/101210095715.htm
Health Behavior News Service, part of the Center for Advancing Health. "Stem cell treatment is effective for certain cases of acute leukemia." ScienceDaily. www.sciencedaily.com/releases/2010/12/101210095715.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins